We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 491 results
  1. FBW7/GSK3β mediated degradation of IGF2BP2 inhibits IGF2BP2-SLC7A5 positive feedback loop and radioresistance in lung cancer

    Background

    The development of radioresistance seriously hinders the efficacy of radiotherapy in lung cancer. However, the underlying mechanisms by...

    Zhiyuan Zhou, Bin Zhang, ... Kunyu Yang in Journal of Experimental & Clinical Cancer Research
    Article Open access 29 January 2024
  2. m6A reader IGF2BP2 promotes lymphatic metastasis by stabilizing DPP4 in papillary thyroid carcinoma

    Lymph node metastasis (LNM) is a major cause of locoregional recurrence of papillary thyroid carcinoma (PTC). However, the mechanisms responsible for...

    Wenlong Wang, Ying Ding, ... **nying Li in Cancer Gene Therapy
    Article 15 December 2023
  3. The m6A reader IGF2BP2 promotes esophageal cell carcinoma progression by enhancing EIF4A1 translation

    Esophageal squamous cell carcinoma (ESCC) is one of most prevalent cancers worldwide, especially in China. Lacking in depth mechanism study,...

    Yuan Li, Zhuya **ao, ... Zuhua Chen in Cancer Cell International
    Article Open access 09 May 2024
  4. KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma

    Background

    Head and neck squamous carcinoma (HNSCC) is known for its high aggressiveness and susceptibility to cervical lymph node metastasis, which...

    Hongshi Cai, Jianfeng Liang, ... **song Hou in Journal of Experimental & Clinical Cancer Research
    Article Open access 05 March 2024
  5. Bioinformatic identification reveals a m6A-binding protein, IGF2BP2, as a novel tumor-promoting gene signature in thyroid carcinoma

    N6-methyladenosine (m6A) modification plays a crucial role in thyroid carcinoma (THCA). Insulin-like growth factor 2 binding protein 2 (IGF2BP2) is a...

    Yang **e, Junqi **ao, ... **angtai Zeng in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 30 January 2024
  6. IGF2BP2 promotes lncRNA DANCR stability mediated glycolysis and affects the progression of FLT3-ITD + acute myeloid leukemia

    Internal tandem duplication (ITD) is the most common type of FLT3 mutation (FLT3-ITD), accounting for about 25% of AML patients. The expression of...

    Shenghao Wu, Changwei Chi, ... Zhen Liu in Apoptosis
    Article Open access 15 April 2023
  7. IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway

    Circular RNAs (circRNAs) represent a class of covalently closed, single-stranded RNAs and have been linked to cancer progression. N6-methyladenosine...

    Rui Shi, Rong Zhao, ... Hongbo Wang in Cancer Gene Therapy
    Article Open access 22 May 2024
  8. Circular RNA circEYA3 promotes the radiation resistance of hepatocellular carcinoma via the IGF2BP2/DTX3L axis

    Background

    Hepatocellular carcinoma (HCC) has a high incidence and mortality rate despite various treatment options, including 125 I seed...

    Pan Hu, Letao Lin, ... Yanling Zhang in Cancer Cell International
    Article Open access 02 December 2023
  9. m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1

    Prostate cancer (PCa) is a malignant tumor of the urinary system. CircABCC4 has been demonstrated to promote the development of PCa; however, its...

    Changkun Huang, Ran Xu, ... Hongyi Jiang in Cancer Gene Therapy
    Article 10 August 2023
  10. m6A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma

    Background

    Lung adenocarcinoma (LUAD) is a common type of lung cancer with a high risk of metastasis, but the exact molecular mechanisms of metastasis...

    Han Fang, Qi Sun, ... **cheng Song in Molecular Cancer
    Article Open access 23 June 2023
  11. A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer

    Aim

    Chemoresistance is a major cause of treatment failure in colorectal cancer (CRC) therapy. In this study, the impact of the IGF2BP family of...

    Sandra Kendzia, Susanne Franke, ... Sonja M. Kessler in Molecular Cancer
    Article Open access 30 May 2023
  12. IGF2BP2-induced circRUNX1 facilitates the growth and metastasis of esophageal squamous cell carcinoma through miR-449b-5p/FOXP3 axis

    Background

    Esophageal squamous cell carcinoma (ESCC) is one of the most common digestive malignancies with relatively high morbidity and mortality....

    Chang Wang, Mingxia Zhou, ... Fucheng He in Journal of Experimental & Clinical Cancer Research
    Article Open access 15 December 2022
  13. Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis

    Introduction

    Esophageal squamous cell carcinoma (ESCC) represents a major malignancy with poor clinical outcomes. Long noncoding RNAs (lncRNAs) are...

    Yuhang **ao, **ming Tang, ... Min Su in Biomarker Research
    Article Open access 16 August 2022
  14. CircEZH2/miR-133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m6A-modified CREB1 mRNA

    Background

    Aberrant expression of circular RNAs (circRNAs) contributes to the initiation and progression of human malignancies, but the underlying...

    Bing Yao, Qinglin Zhang, ... Qiang Zhan in Molecular Cancer
    Article Open access 30 June 2022
  15. ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner

    The process of post-transcriptional regulation has been recognized to be significantly impacted by the presence of N 6-methyladenosine (m6A)...

    **hao Chen, Mujie Ye, ... Qiyun Tang in Journal of Translational Medicine
    Article Open access 19 October 2023
  16. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner

    Background

    Lymph node metastasis is the main cause of poor prognosis of head and neck squamous carcinoma (HNSCC) patients. N6-methyladenosine (m6A)...

    Dan Yu, Min Pan, ... Guohua Hu in Journal of Experimental & Clinical Cancer Research
    Article Open access 03 January 2022
  17. CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502–5p/KRAS and IGF2BP2/Myc axes

    Background

    Emerging studies have revealed the potent functions of circRNAs in breast cancer tumorigenesis. However, the biogenesis, biofunction and...

    Jie Li, **nya Gao, ... Nu Zhang in Molecular Cancer
    Article Open access 25 October 2021
  18. Insertion/deletion variants within the IGF2BP2 gene identified in reported genome-wide selective sweep analysis reveal a correlation with goat litter size

    Insulin-like growth factor 2 mRNA-binding protein 2 ( IGF2BP2 , also called IMP2 ) plays an essential role in the development and maturation of germ...

    Dongyun **n, Yangyang Bai, ... **anyong Lan in Journal of Zhejiang University-SCIENCE B
    Article 18 September 2021
  19. The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers

    The human insulin-like growth factor 2 (IGF2) mRNA binding proteins 2 (IGF2BP2/IMP2) is an RNA-binding protein that regulates multiple biological...

    **yan Wang, Lijuan Chen, ** Qiang in Cancer Cell International
    Article Open access 10 February 2021
  20. LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification

    Background

    Increasing studies have shown that long noncoding RNAs (lncRNAs) are pivotal regulators participating in carcinogenic progression and tumor...

    **fu Hou, Sen Meng, ... ** Bai in Journal of Experimental & Clinical Cancer Research
    Article Open access 01 February 2021
Did you find what you were looking for? Share feedback.